March 4, 2022
2022 St. Louis Dealmaker of the Year
The continued success of Immunophotonics is driven by the dedication and hard work of our team. Immunophotonics was one of...
Read More
February 17, 2022
Immunophotonics Awarded $2.4 Million SBIR Grant by the National Cancer Institute
Immunophotonics, Inc. was recently awarded a Small Business Innovative Research (SBIR) Phase I and Phase II Fast-Track grant for research...
Read More
February 2, 2022
Wei R. Chen B Cell Paper Publication
Hot off the press: Another part of the mechanism of action of how IP-001 (GC) remodels the tumor microenvironment revealed!...
Read More
January 19, 2022
SPIE Photonics West and BiOS Expo, Jan 22 – 27 in San Francisco
If you are interested in the interface between cancer immunotherapy innovation and photonics, then catch up with Tomas Hode, PhD,...
Read More
September 14, 2021
USPTO Issues Patent Covering Immunophotonics’ Lead Drug Candidate, IP-001
Immunophotonics is pleased to announce that the United States Patent and Trademark has issued U.S. Patent No. 11111316, which covers...
Read More
September 7, 2021
Immunophotonics Switzerland (IPS Biopharma) Invited to Present at Swiss Biotech Day
Immunophotonics Switzerland (IPS Biopharma) will be presenting at the Swiss Biotech Day in the Emerging Company session hosted by BB...
Read More
September 1, 2021
Immunophotonics Publishes Follow-up Feature in Nature Biopharma Dealmakers
Immunophotonics is excited to be featured in the September 2021 oncology issue of Nature Biopharma Dealmakers. Read what Dr. Markus...
Read More
March 1, 2021
Immunophotonics Featured in Nature Biopharma Dealmakers
Immunophotonics has been featured in the March oncology issue of Nature Biopharma Dealmakers (www.nature.com/articles/d43747-021-00020-2 ). Nature selects only a handful...
Read More
February 25, 2021
Study Shows IP-001 to Amplify Tumoricidal and Immune Effect of Cancer Ablation Therapies
A paper recently published in Cells has described how Immunophotonics' immune-stimulating drug IP-001 was shown to be effective against metastatic...
Read More
November 10, 2020
Immunophotonics Announces First Patient Treated in Swiss Clinical Trial
ST. LOUIS and BERN, Switzerland, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. announces the first patient treated in the...
Read More